Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02454322 · ClinicalTrials.gov registry record
The Effect of Magnesium on Maternal Mood, Cognitive Function, and Birth Experience
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 300
- Enrollment target
NCT02454322 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 300 participants.
The verdict
NCT02454322 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
Magnesium is sometimes used to prevent seizures in the setting of hypertensive disorders of pregnancy. The primary aim of this study is to determine if women who receive magnesium are less likely to experience postpartum depression. Other aims include examining the relationship between receiving magnesium and cognitive function and birth experience.
Interventions
- DRUG Magnesium Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2015-05 |
| Est. Completion | 2021-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02454322
The ClinicalTrials.gov registry entry for NCT02454322 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnesium Sulfate is the first listed.
NCT02454322 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02454322 about?
NCT02454322 is a clinical study titled "The Effect of Magnesium on Maternal Mood, Cognitive Function, and Birth Experience". Magnesium is sometimes used to prevent seizures in the setting of hypertensive disorders of pregnancy. The primary aim of this study is to determine if women who receive magnesium are less likely to experience postpartum depression. Other aims include examining the relationship between receiving mag...
What is the current status of trial NCT02454322?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2015-05. Estimated completion is 2021-12.
What interventions are being tested in trial NCT02454322?
The interventions under investigation include: Magnesium Sulfate (DRUG).
Who is sponsoring clinical trial NCT02454322?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.